Separating therapeutic efficacy from glucocorticoid side-effects in rodent arthritis using novel, liposomal delivery of dexamethasone phosphate: long-term suppression of arthritis facilitates interval treatment
Open Access
- 1 January 2009
- journal article
- Published by Springer Science and Business Media LLC in Arthritis Research & Therapy
- Vol. 11 (6), R190
- https://doi.org/10.1186/ar2889
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomesJournal of Controlled Release, 2006
- New Glucocorticoids on the Horizon: Repress, Don't Activate!2005
- The role of glucocorticoid action in the pathophysiology of the Metabolic SyndromeNutrition & Metabolism, 2005
- Glucocorticoids in the treatment of rheumatic diseases: An update on the mechanisms of actionArthritis & Rheumatism, 2004
- Complete remission of experimental arthritis by joint targeting of glucocorticoids with long‐circulating liposomesArthritis & Rheumatism, 2003
- Interactions Between the Hypothalamo-Pituitary-adrenal Axis and the Immunological SystemEndocrine Updates, 2003
- SEGRAs: a novel class of anti-inflammatory compounds.Published by Springer Science and Business Media LLC ,2002
- The effect of dexamethasone on body and organ growth of normal and IGF-II-transgenic miceJournal of Endocrinology, 1999
- Urinary hydroxypyridinium crosslinks of collagen in population-based screening for overt vertebral osteoporosis: Results of a pilot studyJournal of Bone and Mineral Research, 1994
- Pharmacokinetics of dexamethasone and its phosphate esterBiopharmaceutics & Drug Disposition, 1987